BRIEF—Neuraxpharm expands into Poland

European firm Neuraxpharm has launched a new Polish subsidiary. The company wants to build its position as a CNS specialist in Poland, offering nutraceuticals, standard generics and added value medicines.

Chief executive Jörg-Thomas Dierks said: “Neuraxpharm today has a direct presence in nine European countries and establishing Neuraxpharm Polska reinforces our ambition to be a leading CNS player in the CEE region and help bring differentiated products to local patients and healthcare professionals.”

Neuraxpharm aims to launch five new CNS products in the country in 2019.